| Document |
Document Title |
|
WO/2009/075186A1 |
Disclosed is a method for producing a 4-deoxy-4-fluoro-D-glucose derivative, wherein a D-galactose derivative is reacted with sulfuryl fluoride (SO2F2), trifluoromethanesulfonyl fluoride (CF3SO2F) or perfluorobutanesulfonyl fluoride (C4F...
|
|
WO/2009/070921A1 |
The antimelancholic medicine or health care products prepared with jujube cAMP materials and preparative method are provided in the present invention.
|
|
WO/2009/067846A1 |
The invention discloses a purifying method of monoglycoside acid which comprises selective oxidizing primary hydroxy group of the monoglycoside, exchanging the reacted composite liquid through an activated strong acid cation exchange res...
|
|
WO/2009/065275A1 |
A bionic catalyst for hydrolyzing cellulose and hemicellulose and its preparation method. The catalyst comprises double acid radical catalytic portions and cellulose-linking portions, and can be used under room temperature and high tempe...
|
|
WO/2009/058852A2 |
The incorporation of a minor groove binder spaced close to one member of a matched FRET set in a minor groove binder-oligonucleotide conjugate significantly reduces background fluorescence of a FRET probe or pair of probes and, consequen...
|
|
WO/2009/059210A1 |
A method for labeling biological molecules and synthetic molecules that contain a geminal diol, such as RNA, carbohydrates or glycoproteins, using a periodate sequestering agent is provided. Compositions and kits for use in the labeling ...
|
|
WO/2009/037268A2 |
The invention relates to a method for the fluid-phase synthesis of a polymer formed from n monomers.
|
|
WO/2009/036673A1 |
The present invention relates to a method to dispose plant fibers, in particular to a method to hydrolyze the plant fibers with concentrated sulfuric acid to prepare a main hydrolysate. The plant fibers are mixed with sulfuric acid in ba...
|
|
WO/2009/036385A2 |
Various embodiments provide, for example, vectors, expression cassettes, and cells useful for transgenic expression of nucleic acid sequences. In various embodiments, vectors can contain plastid-based sequences of unicellular photosynthe...
|
|
WO/2009/031469A1 |
It is intended to provide a high-purity aqueous sugar solution by increasing a recovery rate of a cluster acid serving as a hydrolysis catalyst for cellulose in saccharification and separation of cellulose using a cluster acid catalyst. ...
|
|
WO/2009/023191A2 |
The present invention includes a process involving a one-pot reaction for preparing erythromycin 9-oxime salt comprising: (a) reacting erythromycin thiocyanate with an ammonium source to obtain erythromycin free base; (b) oximating the C...
|
|
WO/2009/007736A1 |
A process for the preparation of an oligonucleotide having at least one phosphate internucleotide linkage (I) provided. The process comprises the steps of: a) forming a nascent oligonucleotide comprising a phosphorus (III) internucleotid...
|
|
WO/2009/006613A1 |
The present invention relates to compositions and methods of their production and use, including use in increasing de-N-acetyl sialic acid antigen of a mammalian cell and methods that exploit the increase in deNAc sialic acid antigen on ...
|
|
WO/2009/006446A2 |
This invention pertains to methods for cloning microRNA (miRNA) and other small ribonucleic acid (RNA) species from relevant cell sources.
|
|
WO/2009/002769A1 |
The present invention discloses A process for producing a carrageenan composition, comprising the steps of: cleaning kappa carrageenan-containing seaweed in water; treating the cleaned seaweed with an aqueous treatment solution, the aque...
|
|
WO/2009/002817A1 |
The present invention discloses a carrageenan composition comprising: sodium in the range of about 5.410 to about 8.230%, preferably about 6.300 to about 8.230%, and more preferably about 7.380 to about 8.230%; potassium in the range of ...
|
|
WO/2009/002727A1 |
Disclosed is a carrageenan composition comprising sodium, potassium, calcium and magnesium Further disclosed are uses for the carageenan composition which include a food, an air freshener, a personal care product, a dentifrice, and a pha...
|
|
WO/2009/000145A1 |
The invention discloses the use of paeoniflorin or its pharmaceutical acceptable salts or solvates as single active ingredient in the manufacture of medicaments for treating depression and its complicated diseases or disorders. The inven...
|
|
WO2008115198A9 |
The present invention presents the isolation, characterization and synthesis of the HF-PS and BcIA-OS oligosaccharides of Bacillus anthracis. Also presented are antibodies that bind to such saccharide moieties and various methods of use ...
|
|
WO/2008/157515A1 |
The present invention relates to cloning target nucleic acids using phage packaging mechanisms. Packaging initiation sites may be introduced into the target DNA. Components of a phage packaging system may be combined with the target DNA ...
|
|
WO/2008/154412A2 |
The disclosure provides a simple and effective way of synthesizing robust organic- inorganic hybrid gels and ultra-thin films using vaporization of a gel precursor. The gels are synthesized at relatively low temperature allowing the acti...
|
|
WO/2008/152386A1 |
The invention relates to a process for preparing furanose derivatives, to furanose intermediates used in said process and to the use of said derivatives in the manufacture of atorvastatin.
|
|
WO/2008/152207A1 |
The present invention is directed to a novel saccharide composition isolated from a yeast culture. The invention is also directed to yeast cell based saccharide composition with increased water-solubility. The saccharide compositions dis...
|
|
WO/2008/150379A1 |
A process for preparing a sucralose-6-ester, a key intermediate to sucralose. The process contains (a) creating a heterogeneous mixture comprising a first phase comprising a sucrose-6-ester and a second phase comprising a chlorinating re...
|
|
WO/2008/147725A1 |
Exemplary embodiments of this invention encompass a method for purifying a substantially crude stevioside, methods for preparing polymorphic and amorphous forms of stevioside, and the polymorphic and amorphous forms prepared therefrom.
|
|
WO/2008/147472A1 |
A novel method for the synthesis of ethers of anhydrosugars, such as isosorbide, isomannide, and isoidide, is disclosed. The bisglycidyl ethers are useful as substitutes for bisphenol A in the manufacture of thermoset epoxy ethers. Anhyd...
|
|
WO/2008/142155A2 |
The present invention concerns a method for preparing C-6 phosphorylated D- aldohexoses and C-6 phosphorylated D-aldohexose derivatives, new C-6 phosphorylated D-aldohexoses derivatives and uses thereof. The method comprises incubating p...
|
|
WO/2008/138243A1 |
Provided is a preparation method of icaritin, comprising treating the icariin with β-glucosidase in ethanol-water solution, then obtaining the icaritin by centrifugation and recrystallization. Also provided is a preparation method of ic...
|
|
WO/2008/138389A1 |
The invention relates to a method of preparation of a quaternary amine having formula 2, by reacting an epoxide having formula 3, Formula 3 with an aliphatic tertiairy amine group in the presence of a suitable Lewis acid.
|
|
WO/2008/130985A2 |
A transgenic seed or plant of a corn, cotton, rapeseed or soybean species having a recombinant chromosome with multiple transgenes for imparting traits to said seed or its plant. Useful traits include herbicide tolerance, insect resistan...
|
|
WO/2008/129530A1 |
Provided is a process for preparing gemcitabine or a salt thereof, which preferably includes selectively precipitating the β-anomer of a 3',5'-di-O-protected-N4-trimethylsilyl-2'-deoxy-2',2'-difluo
rocytidine, removing the protecting gr...
|
|
WO/2008/128216A1 |
Methods for labeling glycans that include a step of freeze-drying a labeled glycan preparation. The labeled glycan preparation is maintained in a substantially frozen state for the duration of the freeze-drying process.
|
|
WO/2008/123256A1 |
Disclosed is a catalyst material which comprises an aggregate of nanoneedles mainly composed of R-type manganese dioxide and has a mesoporous porous structure. The catalyst material enables to oxidatively decompose water at room temperat...
|
|
WO/2008/113585A1 |
The invention concerns a method for the enzymatic treatment of raw polymeric feedstock comprising the following steps: (a) preferably separation of soluble components from the raw polymeric feedstock, (b) treating the raw polymeric feeds...
|
|
WO2008052077B1 |
One embodiment of the present inventionis a process of making sucrose-6-ester from sucrose by transesterification in the presence of a solid super acid catalyst such as SO4 2-
|
|
WO/2008/105593A1 |
The present invention discloses a method for preparing highly pure tri-O-acetyl-5-deoxy-β-D-ribofuranose which comprises a highly stereoselective acetylation step of 1-methylacetonide, and the pure β-anomer thus obtained can be advanta...
|
|
WO/2008/103618A1 |
The present invention includes a xyloside for use in inducing synthesis of a glycosaminoglycan in a cell, the xyloside having a chemical structure of one of Formula (1), Formula (2), Formula (3), Formula (4), Formula (5), Formula (6), Fo...
|
|
WO/2008/101007A2 |
The present invention relates to methods and catalysts for hydrolyzing complex carbohydrates. In an embodiment, the invention includes a process for producing monosaccharides from a complex carbohydrate feedstock including the operations...
|
|
WO/2008/092275A1 |
A process for extracting phytochemicals from plants. The process generally comprises controllably slurrying a selected plant material in a volume of water, adding a selected enzyme the the slurry while it is controllably agitated, then h...
|
|
WO/2008/093239A1 |
A more efficient method for producing glucosamine from microbial biomass such as, for example, fungal biomass is disclosed. In one embodiment, a method for obtaining glucosamine from fungal biomass includes providing fungal biomass conta...
|
|
WO/2008/089669A1 |
The present invention relates to novel pharmaceutical compositions comprising Epimedium wushanense Ying extracts, their methods of preparation, and their use in inhibiting thrombosis and lipid deposition. Also provided by the present inv...
|
|
WO/2008/091547A2 |
The invention provides methods of purifying rebaudioside A from a mixture comprising glycosides of the plant Stevia rebaudiana. The methods of the invention are useful for preparing highly pure rebaudioside A compositions from crude Stev...
|
|
WO/2008/084197A1 |
The present application discloses a process for the synthesis of a sucrose-6-ester comprising: (a) forming a first reaction mixture comprising sucrose, a polar aprotic solvent, and an organotin-based acylation promoter; (b) removal of wa...
|
|
WO/2008/081270A2 |
There is described a process for the preparation of 3,6-di-O-acetyl-D-glycals by C4->C6 acyl migration by treatment of corresponding 3,4-di-O-acetyl-D-glycals with a buffer at pH of from 8.6 to 9.5. The starting 3,4-di-O-acetyl-D-glycals...
|
|
WO/2008/077640A1 |
A process for the hydrogenation of a ketose or a ketose-containing sugar mixture to produce a product mixture comprising at least two stereoisomeric sugar alcohols is disclosed. The process comprises the provision of a reaction mixture c...
|
|
WO/2008/071571A1 |
The invention relates to a novel process for the preparation of a 4'-azido cytidine of the formula (I) of a hydrate or of a pharmaceutically accepted salt thereof. The 4'-azido cytidine of formula (I) is useful for treating virus mediate...
|
|
WO2008015694B1 |
This invention comprises an improved process for recovery and purification of DMF from an aqueous process stream containing DMF with or without inorganic impurities, particularly from process stream of a process of manufacture of the hig...
|
|
WO/2008/061984A2 |
The invention relates to a method for extracting and purifying aloin that comprises the following steps: a) processing aerial parts of Aloe Vera with water; b) recovering the optionally concentrated processing water; c) separating liquid...
|
|
WO/2008/061480A1 |
The present invention provides a mangiferin calcium having the following formula and its preparation and use. The said mangiferin calcium can lower plasma insulin, glucose, lipid, and also can improve the solubility, oral bioavailability...
|
|
WO/2008/057263A2 |
Improved processes for the purification of crude polyol-containing compositions (e.g., glycerol-containing compositions) using a sweep gas are reported. The processes may be used to strip polyols from crude polyol compositions that conta...
|
